The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2023

Filed:

May. 13, 2022
Applicants:

Taixing Dongsheng Bio-tech Co., Ltd, Taixing, CN;

Jiangnan University, Wuxi, CN;

Inventors:

Xinrui Zhao, Wuxi, CN;

Bohan Zhang, Wuxi, CN;

Jingwen Zhou, Wuxi, CN;

Guocheng Du, Wuxi, CN;

Jianghua Li, Wuxi, CN;

Jian Chen, Wuxi, CN;

Fei Yu, Wuxi, CN;

Wei Lu, Taixing, CN;

Yuan Qian, Taixing, CN;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/805 (2006.01); A23L 27/26 (2016.01); C12N 1/16 (2006.01); A23J 1/18 (2006.01); C12N 15/81 (2006.01); A23J 3/04 (2006.01); C12P 21/02 (2006.01); C12N 15/52 (2006.01); B01D 15/42 (2006.01); B01D 15/36 (2006.01); B01D 15/34 (2006.01); B01D 69/02 (2006.01); C12R 1/84 (2006.01);
U.S. Cl.
CPC ...
C12P 21/02 (2013.01); A23J 1/18 (2013.01); B01D 15/34 (2013.01); B01D 15/363 (2013.01); B01D 15/426 (2013.01); B01D 69/02 (2013.01); C07K 14/805 (2013.01); C12N 1/165 (2021.05); C12N 15/52 (2013.01); C12N 15/815 (2013.01); C12Y 302/01001 (2013.01); C12Y 302/01003 (2013.01); C12Y 302/01007 (2013.01); C12Y 302/01017 (2013.01); C12Y 302/01026 (2013.01); B01D 2325/20 (2013.01); C12N 2800/102 (2013.01); C12R 2001/84 (2021.05);
Abstract

The disclosure discloses a genetically engineered strain for producing porcine myoglobin and fermentation and purification thereof, and belongs to the technical field of genetic engineering. The disclosure realizes efficient secretion and expression of porcine myoglobin by integrating the gene of porcine myoglobin in. On this basis, optimization of the medium and culture conditions of recombinantcan significantly increase the titer of porcine myoglobin, so that the titer can reach 285.42 mg/L under fermenter conditions. In addition, by creatively adding different concentrations of ammonium sulfate to fermentation broth step by step, the purity of myoglobin obtained by final concentration is up to 88.0%, and the purification rate is up to 66.1%. The disclosure realizes efficient expression and high purification of porcine myoglobin from various steps such as synthesis, fermentation and purification of porcine myoglobin, and provides broad prospects for industrial production of porcine myoglobin.


Find Patent Forward Citations

Loading…